Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Mustafa, Merter"'
Autor:
Atakan Tekinalp, Ayfer Gedük, Aydan Akdeniz, Esra Terzi Demirsoy, Vildan Gürsoy, Müzeyyen Aslaner Ak, Metin Bağcı, Sema Seçilmiş, Fatma Keklik Karadağ, Ayşe Oruç Uysal, Ali Doğan, Sinan Demircioğlu, Haşim Atakan Erol, Ceyda Aslan, Fahir Özkalemkaş, Şehmus Ertop, Mehmet Dağlı, Mehmet Sinan Dal, Güray Saydam, Mustafa Merter, Cihan Ural, Özcan Çeneli
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 4, Pp 242-250 (2023)
Objective: This study aimed to evaluate patients with relapsed/ refractory multiple myeloma (RRMM) who underwent daratumumab (DARA) therapy. Materials and Methods: This multicenter retrospective study included 134 patients who underwent at least two
Externí odkaz:
https://doaj.org/article/4debcdb81b4a4484a3947f563fe04669
Autor:
İstemi Serin, Mehmet Hilmi Doğu, Ömer Ekinci, Gülsüm Akgün Çağlıyan, Abdulkadir Baştürk, Merih Reis Aras, Sinan Demircioğlu, Burhan Turgut, Mustafa Merter, Sibel Kabukçu Hacıoğlu, Metin Bağcı, Murat Albayrak, Serdal Korkmaz, Mehmet Ali Erkurt, Mehmet Sinan Dal, Fadime Ersoy Dursun, Anıl Tombak, İsmet Aydoğdu, Turgay Ulaş, Fevzi Altuntaş
Publikováno v:
İstanbul Medical Journal, Vol 24, Iss 2, Pp 120-125 (2023)
Introduction:Ruxolitinib is a small -molecule inhibitor of the JAK1/2 pathway. This study aimed to reveal the results and side-effect profile of the use of ruxolitinib as a treatment option in polycythemia vera (PV).Methods:A total of 34 patients wit
Externí odkaz:
https://doaj.org/article/2f9813f1062246cfa7c5bb2a592ed5f8
Autor:
Hale Kıvrak, Seher Yüksel, Can Ateş, Mustafa Merter, Gülşah Kaygusuz, Muhit Özcan, Işınsu Kuzu
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 3, Pp 178-187 (2022)
Objective: Clinical and pathological differential diagnosis of small B-cell lymphomas (SBCLs) is still controversial and may be difficult due to their overlapping morphology, phenotype, and differentiation to plasma cells. We aimed to examine the exp
Externí odkaz:
https://doaj.org/article/b5dfec53013b43799cafb5fe4b3ca34b
Lenalidomide treatment in relapsed/refractory B-cell lymphomas: A single center real-life experience
Autor:
Mustafa Merter, Ayse Uysal
Publikováno v:
Medicine Science, Vol 11, Iss 2, Pp 757-61 (2022)
As an immunomodulatory drug, lenalidomide has been shown to have anti-lymphoma activity and is used in combination with several agents in the treatment of patients with relapsed/refractory disease. In this study, we aimed to evaluate the efficiency o
Externí odkaz:
https://doaj.org/article/44dc1cd38aa8443a94b6d95b9dc8fa5c
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S44-S45 (2021)
Objective: Bisphosphonates are pyrophosphate analogs with a high affinity for calcium crystals. Due to the affinity of bisphosphonates for calcium, they bind rapidly to calcium-containing hydroxyapatite crystals, especially in the resorption zone. In
Externí odkaz:
https://doaj.org/article/65dad6aaf61a40759dfd643744d47e14
Publikováno v:
LLM Dergi. 7:29-34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba3000a26b911ad91d50113610b83d33
https://doi.org/10.5578/llm.20229904
https://doi.org/10.5578/llm.20229904
Autor:
Ayse Uysal, Mustafa Merter
Publikováno v:
LLM Dergi. 6:85-89
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fac0832d1f3226c7b9b43fa103e60234
https://doi.org/10.5578/llm.20229704
https://doi.org/10.5578/llm.20229704
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 17- (2020)
Externí odkaz:
https://doaj.org/article/a2cc8636a4114f32be999981eb4962d7
Publikováno v:
Journal of Clinical Apheresis. 37:606-610
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdcdee15762b84e69ec2c12c8694cb94
https://doi.org/10.1002/jca.22013
https://doi.org/10.1002/jca.22013
Autor:
Anıl Tombak, Mehmet Ali Uçar, Aydan Akdeniz, Eyüp Naci Tiftik, Deniz Gören Şahin, Olga Meltem Akay, Murat Yıldırım, Oral Nevruz, Cem Kis, Emel Gürkan, Şerife Medeni Solmaz, Mehmet Ali Özcan, Rahşan Yıldırım, İlhami Berber, Mehmet Ali Erkurt, Tülin Fıratlı Tuğlular, Pınar Tarkun, İrfan Yavaşoğlu, Mehmet Hilmi Doğu, İsmail Sarı, Mustafa Merter, Muhit Özcan, Esra Yıldızhan, Leylagül Kaynar, Özgür Mehtap, Ayşe Uysal, Fahri Şahin, Ozan Salim, Mehmet Ali Sungur
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 4, Pp 273-280 (2016)
Objective: In this study, we aimed to investigate the efficacy and safety of azacitidine (AZA) in elderly patients with acute myeloid leukemia (AML), including patients with >30% bone marrow (BM) blasts. Materials and Methods: In this retrospective m
Externí odkaz:
https://doaj.org/article/991999bdfbb345eea13143fc24d2544e